| Drug Name |
Griseofulvin |
| Drug ID |
BADD_D01042 |
| Description |
An antifungal antibiotic. Griseofulvin may be given by mouth in the treatment of tinea infections. |
| Indications and Usage |
For the treatment of ringworm infections of the skin, hair, and nails, namely: tinea corporis, tinea pedis, tinea cruris, tinea barbae, cradle cap or other conditions caused by Trichophyton or Microsporum fungi. |
| Marketing Status |
approved; investigational; vet_approved |
| ATC Code |
D01AA08; D01BA01 |
| DrugBank ID |
DB00400
|
| KEGG ID |
D00209
|
| MeSH ID |
D006118
|
| PubChem ID |
441140
|
| TTD Drug ID |
D0C1SF
|
| NDC Product Code |
0781-5514; 23155-865; 60264-310; 0472-0013; 42794-012; 62135-494; 64980-184; 0713-0850; 49452-3363; 23155-864; 62135-496; 64980-185; 62135-495; 64980-186; 71052-109; 0781-5515 |
| UNII |
32HRV3E3D5
|
| Synonyms |
Griseofulvin | Grisefuline | Gris-PEG | Gris PEG | GrisPEG | Grisactin | Fulvicin-U-F | Fulvicin U F | FulvicinUF | Grifulvin V |
